BILLERICA, Mass., Jan. 30, 2020 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...
BILLERICA, Mass., May 10, 2021 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ:CFMS) today announced 510(k) clearance by the U.S. Food and Drug Administration for the Company’s Identity Imprint Knee ...
Patients do not conform to a one-size-fits-all implant model, especially when it comes to knee replacements. Off-the-shelf implants often leave room for improvement in terms of fit and comfort because ...
Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards BILLERICA, Mass., Feb. 24, ...